• Philip Quirke

    Professor of pathology, University of Leeds, St James's University Hospital

    Philip Quirke has an active research group in bowel cancer as well as being the Academic Training Programme Director for West Yorkshire and the Chair of the NHS Bowel Cancer Screening Programme Pathology Committee. His major interests are in bowel cancer.  The YCR programme concentrates on (i) quality of surgery and multidisciplinary treatment (ii) response to therapy in clinical trials in colorectal cancer contributing to the pathology and molecular pathology assessments (iii) screening and the development of early neoplastic lesions.  We are part of the digital pathology group lead by Dr Darren Treanor in collaboration with computing within the University of Leeds with interests in 3 Dimensional histopathology and genotype – phenotype integration. We collaborate with international colleagues in the Karolinska Hospital, Stockholm, University of Erlangen, University of Aarhus, Denmark, Tokyo University, Cancer Hospital Chennai India.  Phil is an Honorary Fellow of the American College of Colon and Rectal Surgeons, the Association of Coloproctology of Great Britain and Ireland, the Societad de Coloproctology Chile and has received the McKeown and Miles medals.  He chairs the NHS Bowel Cancer Screening Programme and undertakes pathology screening research. He is a fellow of the Academy of Medical Sciences and an NIHR Senior Investigator.


     


     

    Pathology and tumour biology


    http://medhealth.leeds.ac.uk/homepage/246/licap-pathology_and_tumour_biology





    Academic programme


    http://medhealth.leeds.ac.uk/clinicalacademictraining





    Academic training


    https://youtu.be/AdrmSJVYfqk





    Digital pathology


    http://medhealth.leeds.ac.uk/homepage/544/fmh_research-molecular_and_digital_pathology





    Virtual pathology


    http://www.virtualpathology.leeds.ac.uk





    See the powerwall on you tube


    http://www.youtube.com/watch?v=oZGkhKkDG5o





    See 3 dimensional pathology at


    http://www.virtualpathology.leeds.ac.uk/research/3D/3d_vs.php





    See one of our Medical PhD’s views on academic pathology


    https://www.youtube.com/watch?v=lRdZtphiUjE





























     
     

    • Is it time for “excise – evaluate and then resect” in the high-risk patient with early cancer?
      13:30 - 13:55

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy

cookie-close